208 related articles for article (PubMed ID: 7724388)
1. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients.
Nisam S; Kaye SA; Mower MM; Hull M
Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):142-7. PubMed ID: 7724388
[No Abstract] [Full Text] [Related]
2. Mortality benefits and the implantable cardioverter-defibrillator.
Sweeney MO; Ruskin JN
Circulation; 1994 Apr; 89(4):1851-8. PubMed ID: 8149550
[TBL] [Abstract][Full Text] [Related]
3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
4. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
6. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillator follow-up: what everyone needs to know.
Wilbur SL; Marchlinski FE
Cardiol Rev; 1999; 7(4):176-90. PubMed ID: 10423669
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
Daccarett M; Serafimovski N; Machado C
Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
[No Abstract] [Full Text] [Related]
9. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
Böcker D; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
[TBL] [Abstract][Full Text] [Related]
10. How implantable cardioverter-defibrillators work and simple programming.
Bryant RM
Cardiol Young; 2017 Jan; 27(S1):S121-S125. PubMed ID: 28084970
[TBL] [Abstract][Full Text] [Related]
11. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients.
Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z
Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894
[TBL] [Abstract][Full Text] [Related]
12. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
Grimm W; Flores BT; Marchlinski FE
Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
[TBL] [Abstract][Full Text] [Related]
13. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
14. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
15. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
16. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
17. What risk should justify implantable cardioverter defibrillator therapy?
Schläpfer J; Kappenberger L; Fromer M
Am J Cardiol; 1999 Mar; 83(5B):101D-103D. PubMed ID: 10089850
[TBL] [Abstract][Full Text] [Related]
18. Indications for an implantable cardioverter defibrillator (ICD).
Aizawa Y; Chinushi M; Washizuka T
Intern Med; 2004 May; 43(5):360-7. PubMed ID: 15206546
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.
Akhtar M; Jazayeri M; Sra J; Tchou P; Rovang K; Blanck Z; Dhala A; Deshpande S; Axtell K
Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):511-8. PubMed ID: 7681950
[TBL] [Abstract][Full Text] [Related]
20. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
Block M; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
